首页> 外文期刊>Journal of biomolecular screening: The official journal of the Society for Biomolecular Screening >A high-throughput small-molecule ligand screen targeted to agonists and antagonists of the g-protein-coupled receptor GPR54
【24h】

A high-throughput small-molecule ligand screen targeted to agonists and antagonists of the g-protein-coupled receptor GPR54

机译:针对g蛋白偶联受体GPR54的激动剂和拮抗剂的高通量小分子配体筛选

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Recent data have shown that the G-protein-coupled receptor GPR54 (also known as KiSS-1 receptor) regulates GnRH release from the hypothalamus. This essential role of GPR54 in controlling the hypothalamic-pituitary-gonadal axis makes it an attractive target for therapeutic intervention in reproductive and cancer medicine. Currently, there are no small-molecule modulators of GPR54 function for experimental or clinical use. To identify small-molecule compounds that modify GPR54 signal transduction, the authors have adapted a cell-based functional assay for high-throughput screening (HTS) using a commercially available homogeneous time-resolved fluorescence assay for inositol phosphate accumulation. They generated stable Chinese hamster ovary cell transfectants that express human GPR54 for use in this assay. After optimization in an automated HTS environment, they screened a library of 110,000 small-molecule compounds using 2 protocols, one to identify agonists and one to identify antagonists. Hits obtained in the primary screen were confirmed to be active in secondary in vitro assays. Compounds identified as agonists or antagonists from HTS and secondary screening will be characterized to identify agents with the potential to be developed as novel orally active agents to treat hormone-dependent disorders such as abnormal puberty, infertility, endometriosis, and sex steroid-dependent tumors.
机译:最新数据显示,G蛋白偶联受体GPR54(也称为KiSS-1受体)调节下丘脑中GnRH的释放。 GPR54在控制下丘脑-垂体-性腺轴中的这一重要作用使其成为生殖和癌症医学治疗干预的有吸引力的靶标。当前,没有用于实验或临床用途的GPR54功能的小分子调节剂。为了鉴定修饰GPR54信号转导的小分子化合物,作者采用了一种基于细胞的功能测定法进行高通量筛选(HTS),使用了市售的均质时间分辨荧光测定法来分析肌醇磷酸盐的积累。他们生成了稳定的中国仓鼠卵巢细胞转染子,该转染子表达人GPR54,可用于该测定。在自动化的HTS环境中进行优化后,他们使用2种方案筛选了110,000种小分子化合物的文库,一种用于鉴定激动剂,另一种用于鉴定拮抗剂。初步筛选中获得的命中被证实在二次体外测定中具有活性。被鉴定为来自HTS和二次筛选的激动剂或拮抗剂的化合物,其特征在于鉴定出有潜力被开发为新型的口服活性剂,用于治疗激素依赖性疾病,例如青春期异常,不育,子宫内膜异位症和性类固醇依赖性肿瘤。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号